Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3358)
All Articles published online
|
Nov 7, 2005 (publication date) through Sep 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jármay K, Karácsony G, Nagy A, Schaff Z. Changes in lipid metabolism in chronic hepatitis C. World J Gastroenterol 2005; 11(41): 6422-6428 [PMID: 16425410 DOI: 10.3748/wjg.v11.i41.6422] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i41/6422.htm |
| Number | Citing Articles |
| 1 |
Marianna Lakatos, Krisztina Hagymási, Gabriella Lengyel. Fatty liver and hepatitis C virus infection. Orvosi Hetilap 2011; 152(38): 1513 doi: 10.1556/OH.2011.29209
|
| 2 |
Mohamed Emam, Surendra Kumar, Khalil Eslamloo, Albert Caballero-Solares, Jennifer R. Hall, Xi Xue, Hélène Paradis, Robert L. Gendron, Javier Santander, Matthew L. Rise. Transcriptomic response of lumpfish (Cyclopterus lumpus) head kidney to viral mimic, with a focus on the interferon regulatory factor family. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1439465
|
| 3 |
Bing Chen, Umair Iqbal, Shivani K. Desai, Jacob Gries, Elijah Verheyen, Mengdan Xie, Maan El Halabi, Sara Gaines, Ilan Weisberg. The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis. Journal of Viral Hepatitis 2024; 31(10): 633 doi: 10.1111/jvh.13984
|
| 4 |
Roberta Zupo, Fabio Castellana, Sara De Nucci, Giovanni De Pergola, Madia Lozupone, Ilaria Bortone, Marco Castellana, Giancarlo Sborgia, Luisa Lampignano, Gianluigi Giannelli, Francesco Panza, Rodolfo Sardone. Liver Fibrosis and 8-Year All-Cause Mortality Trajectories in the Aging Cohort of the Salus in Apulia Study. Biomedicines 2021; 9(11): 1617 doi: 10.3390/biomedicines9111617
|
| 5 |
Roberta Zupo, Fabio Castellana, Rossella Donghia, Luisa Lampignano, Vito Guerra, Giovanni De Pergola, Madia Lozupone, Ilaria Bortone, Sara De Nucci, Rossella Tatoli, Sarah Tirelli, Giancarlo Sborgia, Gianluigi Giannelli, Francesco Panza, Rodolfo Sardone. Liver frailty and all-cause mortality in the older participants of the Salus in Apulia Study. GeroScience 2022; 44(2): 835 doi: 10.1007/s11357-021-00434-x
|
| 6 |
J. H. Patel, J. F. L. Cobbold, H. C. Thomas, S. D. Taylor-Robinson. Hepatitis C and hepatic steatosis. QJM 2010; 103(5): 293 doi: 10.1093/qjmed/hcp192
|
| 7 |
Josephine H. Li, Xiang Qian Lao, Hans L. Tillmann, Jennifer Rowell, Keyur Patel, Alexander Thompson, Sunil Suchindran, Andrew J. Muir, John R. Guyton, Stephen D. Gardner, John G. McHutchison, Jeanette J. McCarthy. Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology 2010; 51(6): 1904 doi: 10.1002/hep.23592
|
| 8 |
Christian M. Lange, Michael von Wagner, Jörg Bojunga, Thomas Berg, Harald Farnik, Angela Hassler, Christoph Sarrazin, Eva Herrmann, Stefan Zeuzem. Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin. European Journal of Gastroenterology & Hepatology 2010; 22(11): 1303 doi: 10.1097/MEG.0b013e32833de92c
|
| 9 |
Ching-Sheng Hsu, Chun-Jen Liu, Chen-Hua Liu, Chi-Ling Chen, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Metabolic profiles in patients with chronic hepatitis C: a case–control study. Hepatology International 2008; 2(2): 250 doi: 10.1007/s12072-008-9064-3
|
| 10 |
Klara Werling, Zsuzsa Schaff, Elek Dinya, Zsolt Tulassay. Effect of Liver Steatosis on Therapeutic Response in Chronic Hepatitis C Virus Genotype 1 Infected Patients in Hungary. Pathology & Oncology Research 2010; 16(2): 149 doi: 10.1007/s12253-009-9195-4
|
| 11 |
Jacinta A Holmes, William Sievert, Alexander J Thompson.
IL28B
Polymorphism and Genetic Biomarkers of Viral Clearance in Hepatitis C Virus Infection
. Biomarkers in Medicine 2011; 5(4): 461 doi: 10.2217/bmm.11.47
|
| 12 |
Ornit Chiba-Falek, Colton Linnertz, John Guyton, Stephen D. Gardner, Allen D. Roses, Jeanette J. McCarthy, Keyur Patel. Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection. Human Genetics 2012; 131(12): 1911 doi: 10.1007/s00439-012-1220-0
|
| 13 |
Jae Young Jang, Raymond T. Chung. New treatments for chronic hepatitis C. The Korean Journal of Hepatology 2010; 16(3): 263 doi: 10.3350/kjhep.2010.16.3.263
|
| 14 |
Mahmoud Aboelneen Khattab. Targeting host factors: A novel rationale for the management of hepatitis C virus. World Journal of Gastroenterology 2009; 15(28): 3472-3479 doi: 10.3748/wjg.15.3472
|
| 15 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|
| 16 |
Jacqueline G. O'Leary, Jessica L. Chan, Cory M. McMahon, Raymond T. Chung. Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial. Hepatology 2007; 45(4): 895 doi: 10.1002/hep.21554
|
| 17 |
Gabor Lendvai, Katalin Jármay, Gizella Karácsony, Tünde Halász, Ilona Kovalszky, Kornélia Baghy, Tibor Wittmann, Zsuzsa Schaff, András Kiss. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World Journal of Gastroenterology 2014; 20(41): 15343-15350 doi: 10.3748/wjg.v20.i41.15343
|
| 18 |
Lorillee Tallorin, Valerie A. Villareal, Chih-Yun Hsia, Mary A. Rodgers, Dominique J. Burri, Marc-Philipp Pfeil, Paula Montero Llopis, Brett D. Lindenbach, Priscilla L. Yang. Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase. Journal of Biological Chemistry 2020; 295(35): 12426 doi: 10.1074/jbc.RA120.013455
|
| 19 |
Hung-Yu Sun, Pin-Nan Cheng, Chiung-Ying Tseng, Wei-Jen Tsai, Yen-Cheng Chiu, Kung-Chia Young. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection. Gut 2018; 67(7): 1342 doi: 10.1136/gutjnl-2017-313832
|
| 20 |
D. Ramcharran, A. S. Wahed, H. S. Conjeevaram, R. W. Evans, T. Wang, S. H. Belle, L. J. Yee. Serum lipids and their associations with viral levels and liver disease severity in a treatment‐naïve chronic hepatitis C type 1‐infected cohort. Journal of Viral Hepatitis 2011; 18(4) doi: 10.1111/j.1365-2893.2010.01394.x
|
| 21 |
Jian Yang, Hai-Qing Wang, Jia-Yin Yang, Tian-Fu Wen, Bo Li, Wen-Tao Wang, Lu-Nan Yan. Role of the postoperative cholesterol in early allograft dysfunction and survival after living donor liver transplantation. Hepatobiliary & Pancreatic Diseases International 2017; 16(6): 610 doi: 10.1016/S1499-3872(17)60008-0
|
| 22 |
Chong Li, Lungen Lu, Zhongtian Qi, Yongqiang Zhu, Fengtao Su, Ping Zhao, Hui Dong. Transcriptome and miRNome Analysis Provide New Insight Into Host Lipid Accumulation, Innate Immunity, and Viral Persistence in Hepatitis C Virus Infection in vitro. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.535673
|
| 23 |
Naga Venkata Krishna Chand Pothineni, Robert Delongchamp, Srikanth Vallurupalli, Zufeng Ding, Yao Dai, Curt H. Hagedorn, Jawahar L. Mehta. Impact of Hepatitis C Seropositivity on the Risk of Coronary Heart Disease Events. The American Journal of Cardiology 2014; 114(12): 1841 doi: 10.1016/j.amjcard.2014.09.020
|
| 24 |
Elemér Nemesánszky. Clinical consequences of chronic hepatitis C virus infection, diabetes mellitus and steatosis hepatitis. Orvosi Hetilap 2011; 152(22): 882 doi: 10.1556/OH.2011.29107
|
| 25 |
Mary A. Rodgers, Valerie A. Villareal, Esperance A. Schaefer, Lee F. Peng, Kathleen E. Corey, Raymond T. Chung, Priscilla L. Yang. Lipid Metabolite Profiling Identifies Desmosterol Metabolism as a New Antiviral Target for Hepatitis C Virus. Journal of the American Chemical Society 2012; 134(16): 6896 doi: 10.1021/ja207391q
|